HP&M’s David Clissold to Present at 4th Annual CNS Diseases World Summit

June 18, 2014

GTCbio recently announced that it will be holding the 4th Annual CNS Diseases World Summit from September 18-19, 2014 in San Francisco, California. The summit consists of two individual conferences that will run in parallel: (1) the 7th CNS Partnering & Deal-Making conference; and (2) the 8th Neurodegenerative Conditions Research & Development conference.

Hyman, Phelps & McNamara, P.C’s David B. Clissold is scheduled to present at the conference. As such, we’re able to offer FDA Law Blog readers a special 25% discount off of the regular price. To obtain the discount, please use colleague code HPMCNS25 when registering for the conference.